Matches in Wikidata for { <http://www.wikidata.org/entity/Q79782943> ?p ?o ?g. }
- Q79782943 description "article scientifique (publié 2006)" @default.
- Q79782943 description "artikull shkencor i botuar më 01 janar 2006" @default.
- Q79782943 description "artículu científicu espublizáu en xineru de 2006" @default.
- Q79782943 description "im Januar 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79782943 description "scientific article published on 01 January 2006" @default.
- Q79782943 description "wetenschappelijk artikel" @default.
- Q79782943 description "наукова стаття, опублікована в січні 2006" @default.
- Q79782943 name "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 name "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 name "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 type Item @default.
- Q79782943 label "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 label "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 label "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 prefLabel "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 prefLabel "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 prefLabel "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 P1433 Q79782943-93488542-7F11-4776-8C1F-7F0D7042F48E @default.
- Q79782943 P1476 Q79782943-12929A63-4ECC-4FA7-9A96-385B5B5A1726 @default.
- Q79782943 P2093 Q79782943-055879BE-2412-466F-8D40-5659F25B5F47 @default.
- Q79782943 P2093 Q79782943-546BE8B3-7A8B-4DE2-BAD6-B838A72FD854 @default.
- Q79782943 P2093 Q79782943-85A43203-303C-444F-A970-DA68DE48B74E @default.
- Q79782943 P2093 Q79782943-88DB72D3-A241-450F-9D42-1B823CDD74E7 @default.
- Q79782943 P2093 Q79782943-8D45865A-8AEA-40D9-A609-BA2C8AB86417 @default.
- Q79782943 P2093 Q79782943-90F56561-71AF-4674-A99E-9A3B0A1D60EE @default.
- Q79782943 P2093 Q79782943-9BA2A1EB-E279-44BA-947A-CD452F16D8DC @default.
- Q79782943 P2093 Q79782943-F33789D4-B5F3-4437-98DB-28DF873AFC72 @default.
- Q79782943 P2093 Q79782943-FE961DE4-2699-440F-828D-50348F72EAFD @default.
- Q79782943 P2093 Q79782943-FF0D93E1-BAD4-461D-A027-3F9FE8D76095 @default.
- Q79782943 P2860 Q79782943-0884341A-EF26-4A41-AC70-66004CA28B03 @default.
- Q79782943 P2860 Q79782943-08D3076D-6D93-484A-BB97-704B36394B1D @default.
- Q79782943 P2860 Q79782943-0C915A78-2404-4952-872F-D986583DBE85 @default.
- Q79782943 P2860 Q79782943-15489123-6FC8-40EF-B5FE-722E5236B87E @default.
- Q79782943 P2860 Q79782943-1DE19F58-158F-4F8A-815E-EAF2945AE9D9 @default.
- Q79782943 P2860 Q79782943-3C7C65D8-E92C-4B48-8AF9-3D8F3D23B6D8 @default.
- Q79782943 P2860 Q79782943-4E0DF0A8-F3B7-40D1-8C57-D7ACFA4481DB @default.
- Q79782943 P2860 Q79782943-570A9FF2-4C81-4BFB-A7AC-D5EFCB320241 @default.
- Q79782943 P2860 Q79782943-5F7DDAC1-3A8E-4F0B-8CC5-DBDB40C5131D @default.
- Q79782943 P2860 Q79782943-74CCF367-9CDD-4D6F-8ED3-8FB7EAF263A9 @default.
- Q79782943 P2860 Q79782943-75E8E1B1-2542-4660-BB24-CBB4851EA614 @default.
- Q79782943 P2860 Q79782943-9BDF71F3-AFFC-47F2-97C4-C0ED3336CC5D @default.
- Q79782943 P2860 Q79782943-A033C64A-BBC3-4CCA-A47E-ADD2A72298F0 @default.
- Q79782943 P2860 Q79782943-CF584C43-5A4E-40D4-8460-339A96BFC23F @default.
- Q79782943 P2860 Q79782943-DD469AF8-838E-4206-AAC9-7E125FBD3144 @default.
- Q79782943 P2860 Q79782943-EA498564-C500-4B53-9675-8441A15158B4 @default.
- Q79782943 P2860 Q79782943-F2AA6797-1770-4F20-BDC5-F708EA8AF25F @default.
- Q79782943 P2860 Q79782943-FF8B89FD-D9DD-400B-A63D-AF74CE3CAD96 @default.
- Q79782943 P2888 Q79782943-30266AFB-59FF-40C6-8E4B-F6414826E647 @default.
- Q79782943 P304 Q79782943-CDF5E7F5-B8DE-4687-A67A-21DF9210C0AA @default.
- Q79782943 P31 Q79782943-ADDBCB6E-BEF0-41A0-89A6-AE8861EA3445 @default.
- Q79782943 P356 Q79782943-451C30C0-26C6-4872-9665-78427B9DA820 @default.
- Q79782943 P433 Q79782943-34231C69-6AE1-41AE-8A34-D1923DD53514 @default.
- Q79782943 P478 Q79782943-AAFB4A61-6F16-44A0-B20F-E872DA2E212F @default.
- Q79782943 P577 Q79782943-5A987A97-1EE6-4C20-8AC2-1A3251894A90 @default.
- Q79782943 P6179 Q79782943-85B2C96A-C5E4-4CAD-969E-B474D7D882A9 @default.
- Q79782943 P698 Q79782943-5E3800C1-DD49-4194-8711-D49CBF707C95 @default.
- Q79782943 P921 Q79782943-6DF26E1E-8777-4BF0-B5E6-C5676FD28148 @default.
- Q79782943 P921 Q79782943-ADDC5910-0D2E-4476-8E83-F6AC3FC53621 @default.
- Q79782943 P356 MO:23:4:479 @default.
- Q79782943 P698 17303906 @default.
- Q79782943 P1433 Q2152666 @default.
- Q79782943 P1476 "Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer" @default.
- Q79782943 P2093 "Christos Christodoulou" @default.
- Q79782943 P2093 "Christos Papadimitriou" @default.
- Q79782943 P2093 "Dimitrios Pectasides" @default.
- Q79782943 P2093 "Dimosthenis Skarlos" @default.
- Q79782943 P2093 "Eleni Timotheadou" @default.
- Q79782943 P2093 "George Fountzilas" @default.
- Q79782943 P2093 "Helen Gogas" @default.
- Q79782943 P2093 "Ioannis Efstratiou" @default.
- Q79782943 P2093 "Pavlos Papakostas" @default.
- Q79782943 P2093 "Theofanis Economopoulos" @default.
- Q79782943 P2860 Q33365694 @default.
- Q79782943 P2860 Q33502768 @default.
- Q79782943 P2860 Q34247815 @default.
- Q79782943 P2860 Q36251476 @default.
- Q79782943 P2860 Q40623460 @default.
- Q79782943 P2860 Q44362100 @default.
- Q79782943 P2860 Q45023413 @default.
- Q79782943 P2860 Q45050380 @default.
- Q79782943 P2860 Q45251775 @default.
- Q79782943 P2860 Q46493659 @default.
- Q79782943 P2860 Q46522790 @default.
- Q79782943 P2860 Q46658468 @default.
- Q79782943 P2860 Q46691182 @default.
- Q79782943 P2860 Q54071888 @default.
- Q79782943 P2860 Q57578575 @default.
- Q79782943 P2860 Q73042198 @default.
- Q79782943 P2860 Q73544159 @default.
- Q79782943 P2860 Q78111202 @default.
- Q79782943 P2888 mo:23:4:479 @default.
- Q79782943 P304 "479-488" @default.
- Q79782943 P31 Q13442814 @default.
- Q79782943 P356 "10.1385/MO:23:4:479" @default.
- Q79782943 P433 "4" @default.
- Q79782943 P478 "23" @default.
- Q79782943 P577 "2006-01-01T00:00:00Z" @default.
- Q79782943 P6179 "1002538897" @default.
- Q79782943 P698 "17303906" @default.
- Q79782943 P921 Q420436 @default.